麻豆传媒

Houston, TX USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 673274fe31520_demoraes.jpg

Adequate Sleep Significantly Reduces the Risk of Hypertension in Adolescents, According to New Study

Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to have a significantly lower risk of hypertension, according to a new study from UTHealth Houston.
11-Nov-2024 3:30 PM EST Add to Favorites

麻豆传媒: 67251b1c8495a_Houheadshot.jpg

Change of Ownership in Home Health Agencies May Lead to Increased Medicare Spending and Reduced Staffing Levels, According to Uthealth Houston Research

Medicare-certified home health agencies, which are key to allowing older adults to age in place, are increasingly going through ownership changes, raising concerns about health care spending, workforce, and quality of care, according to a study by...
1-Nov-2024 2:15 PM EDT Add to Favorites

麻豆传媒: 670844b77195a_ono.jpg

$8.1M Grant Will Allow Researchers to Study the Role of Skeletal Stem Cells in Craniofacial Bone Diseases and Deformities

Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and deformities. The study is led by Noriaki Ono,...
10-Oct-2024 4:25 PM EDT Add to Favorites

麻豆传媒: 67067be307f34_tv54570234-color-ShethandGiancardo.jpg

UTHealth Houston Awarded $2.5 Million Grant to Improve Outcomes for Stroke Patients with Large Blood Vessel Blockages

Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
9-Oct-2024 8:05 AM EDT Add to Favorites

麻豆传媒: 67059d73b742f_BalasubramanianBijal1.png

Improving Health Outcomes of Underserved Patients Living with Cancer Focus of $4.8m Grant to UTHealth Houston

An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight...
8-Oct-2024 4:05 PM EDT Add to Favorites

麻豆传媒: 6703f55f5b0d7_11.jpg

First Infusion in Houston for New Alzheimer鈥檚 Drug Administered at UTHealth Houston

UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer鈥檚 disease.
7-Oct-2024 10:05 AM EDT Add to Favorites

麻豆传媒: 66f439a38ed9b_DR.TANDONCLINICPHOTOSHOOT-9.jpg

UTHealth Houston鈥檚 Minimally Invasive Treatment Extends Hope to Patients with Medication-Resistant Epilepsy

Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological...
25-Sep-2024 12:05 PM EDT Add to Favorites

麻豆传媒: 66ec5d17222ac_alzstudyphoto1.jpg

Grants for $3.5m From TARCC Fund New Alzheimer鈥檚 Disease Research at UTHealth Houston

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer鈥檚 disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer鈥檚 Research...
19-Sep-2024 1:05 PM EDT Add to Favorites


See All News

Our YouTube Videos
View All >

About

As a comprehensive health science university, the mission of UTHealth Houston is to educate health science professionals, discover and translate advances in the biomedical and social sciences, and model the best practices in clinical care and public health.

We pursue this mission in order to advance the quality of human life by enhancing the diagnosis, treatment, and prevention of disease and injury, as well as promoting individual health and community well-being.

Experts

Twitter

Facebook

close
0.37874